ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för teprenone. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

17 träffar

Bibliografisk träff 2014-04-15

Geranylgeranylacetone blocks doxorubicin-induced cardiac toxicity and reduces cancer cell growth and invasion through RHO pathway inhibition.

Sysa-Shah P, Xu Y, Guo X, Pin S, Bedja D, Bartock R, Tsao A, Hsieh A, Wolin MS, Moens A, Raman V, Orita H, Gabrielson KL.

Mol Cancer Ther · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1158/1535-7163.mct-13-0965

Bibliografisk träff 2014-04-02

Induction of heat-shock protein 70 expression by geranylgeranylacetone shows cytoprotective effects in cardiomyocytes of mice under humid heat stress.

Wang X, Yuan B, Dong W, Yang B, Yang Y, Lin X, Gong G.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0093536

Bibliografisk träff 2014-03-15

Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

Tsutsumi YM, Tsutsumi R, Horikawa YT, Sakai Y, Hamaguchi E, Kitahata H, Kasai A, Kambe N, Tanaka K.

J Anesth · research support, non-u.s. gov't; journal article · DOI 10.1007/s00540-014-1816-8

Bibliografisk träff 2014-03-11

Protective effect of geranylgeranylacetone via enhanced induction of HSPB1 and HSPB8 in mitochondria of the failing heart following myocardial infarction in rats.

Marunouchi T, Inomata S, Sanbe A, Takagi N, Tanonaka K.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2014.02.037

Bibliografisk träff 2014-02-27

Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laser endomicroscopy in indomethacin-induced enteropathy.

Shi S, Wang H, Gao H, Li Z, Chen FX, Zuo XL, Li YQ.

Dig Dis Sci · research support, u.s. gov't, non-p.h.s.; evaluation study; journal article · DOI 10.1007/s10620-014-3076-8

Bibliografisk träff 2014-02-26

Geranylgeranylacetone protects the heart via caveolae and caveolin-3.

Tsutsumi YM, Tsutsumi R, Horikawa YT, Sakai Y, Hamaguchi E, Ishikawa Y, Yokoyama U, Kasai A, Kambe N, Tanaka K.

Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.lfs.2014.02.019

Bibliografisk träff 2014-01-01

Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.

Umegaki E, Kuramoto T, Kojima Y, Nouda S, Ishida K, Takeuchi T, Inoue T, Tokioka S, Higuchi K.

Intern Med · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.2169/internalmedicine.53.1572

Bibliografisk träff 2013-10-01

Suppression of Alzheimer's disease-related phenotypes by geranylgeranylacetone in mice.

Hoshino T, Suzuki K, Matsushima T, Yamakawa N, Suzuki T, Mizushima T.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0076306

Bibliografisk träff 2013-08-31

Protective effect of geranylgeranylacetone against methamphetamine-induced neurotoxicity in rat pheochromocytoma cells.

Lv T, Li Y, Jia J, Shi Z, Bai J.

Pharmacology · research support, non-u.s. gov't; journal article · DOI 10.1159/000353213

Bibliografisk träff 2013-08-14

Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury.

Zhao Z, Faden AI, Loane DJ, Lipinski MM, Sabirzhanov B, Stoica BA.

J Cereb Blood Flow Metab · research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/jcbfm.2013.144

Bibliografisk träff 2013-06-20

Geranylgeranylacetone inhibits melanin synthesis via ERK activation in Mel-Ab cells.

Kim EH, Jeong HS, Yun HY, Baek KJ, Kwon NS, Park KC, Kim DS.

Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.lfs.2013.06.008

Bibliografisk träff 2013-04-01

The role of heat shock protein 70 induced by geranylgeranylacetone in carbon tetrachloride-exposed adult rat testes.

Kamal MM, Omran OM.

Pathophysiology · journal article · DOI 10.1016/j.pathophys.2013.03.003

Bibliografisk träff 2013-01-04

Protective effect of geranylgeranylacetone against radiation-induced delayed effects on human keratinocytes.

Isoir M, Roque T, Squiban C, Milliat F, Mondon P, Mas-Chamberlin C, Benderitter M, Guipaud O, Tamarat R.

Radiat Res · research support, non-u.s. gov't; journal article · DOI 10.1667/rr2717.1

Bibliografisk träff 2012-12-03

Geranylgeranylacetone protects against morphine-induced hepatic and renal damage in mice.

Luo FC, Zhao L, Deng J, Liang M, Zeng XS, Liu H, Bai J.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2012.1217

Bibliografisk träff 2012-05-01

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).

Sakurai K, Nagahara A, Inoue K, Akiyama J, Mabe K, Suzuki J, Habu Y, Araki A, Suzuki T, Satoh K, Nagami H, Harada R, Tano N, Kusaka M, Fujioka Y, Fujimura T, Shigeto N, Oumi T, Miwa J, Miwa H, Fujimoto K, Kinoshita Y, Haruma K.

BMC Gastroenterol · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1186/1471-230x-12-42

Bibliografisk träff 2012-01-01

Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS).

Hongo M, Harasawa S, Mine T, Sasaki I, Matsueda K, Kusano M, Hanyu N, Nakada K, Shibata C.

J Gastroenterol Hepatol · multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1440-1746.2011.06949.x

Bibliografisk träff 2011-03-13

Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C.

Ikeda M, Kawai Y, Mori K, Yano M, Abe K, Nishimura G, Dansako H, Ariumi Y, Wakita T, Yamamoto K, Kato N.

Liver Int · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1478-3231.2011.02499.x